These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 38399953)

  • 21. Evolutionary trajectory of SARS-CoV-2 and emerging variants.
    Singh J; Pandit P; McArthur AG; Banerjee A; Mossman K
    Virol J; 2021 Aug; 18(1):166. PubMed ID: 34389034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.
    Liu D; Chen C; Chen D; Zhu A; Li F; Zhuang Z; Mok CKP; Dai J; Li X; Jin Y; Chen Z; Sun J; Wang Y; Li Y; Zhang Y; Wen L; Zhang Z; Zhuo J; Wang J; Ran W; Wang D; Zhang S; Tang Y; Li S; Lai X; Wei P; Yuan J; Chen F; Huang S; Sun F; Qian Z; Tan W; Zhao J; Peiris M; Zhao J
    Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2202820120. PubMed ID: 36652473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human seasonal coronavirus neutralization and COVID-19 severity.
    Wells DA; Cantoni D; Mayora-Neto M; Genova CD; Sampson A; Ferrari M; Carnell G; Nadesalingam A; Smith P; Chan A; Raddi G; Castillo-Olivares J; Baxendale H; Temperton N; Heeney JL
    J Med Virol; 2022 Oct; 94(10):4820-4829. PubMed ID: 35705514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye.
    Al-Sharif E; Strianese D; AlMadhi NH; D'Aponte A; dell'Omo R; Di Benedetto R; Costagliola C
    Int Ophthalmol; 2021 Jan; 41(1):349-362. PubMed ID: 32880786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses.
    Otter CJ; Fausto A; Tan LH; Khosla AS; Cohen NA; Weiss SR
    Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2218083120. PubMed ID: 37023127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis.
    Du PX; Chou YY; Santos HM; Keskin BB; Hsieh MH; Ho TS; Wang JY; Lin YL; Syu GD
    Anal Chem; 2021 Jun; 93(21):7690-7698. PubMed ID: 34011150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of four endemic human coronaviruses and, reactivity and neutralization capability against SARS-CoV-2 among children in the Philippines.
    Sayama Y; Okamoto M; Saito M; Saito-Obata M; Tamaki R; Joboco CD; Lupisan S; Oshitani H
    Sci Rep; 2023 Feb; 13(1):2310. PubMed ID: 36759702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19.
    Sharma HN; Latimore COD; Matthews QL
    Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
    Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
    Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
    Qin S; Xia X; Shi X; Ji X; Ma F; Chen L
    Bioinformatics; 2021 Jan; 36(21):5133-5138. PubMed ID: 32805023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers.
    Kolehmainen P; Huttunen M; Iakubovskaia A; Maljanen S; Tauriainen S; Yatkin E; Pasternack A; Naves R; Toivonen L; Tähtinen PA; Ivaska L; Lempainen J; Peltola V; Waris M; Kakkola L; Ritvos O; Julkunen I
    Sci Rep; 2023 May; 13(1):8416. PubMed ID: 37225867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Flexible, Extended Coil of the PDZ-Binding Motif of the Three Deadly Human Coronavirus E Proteins Plays a Role in Pathogenicity.
    Schoeman D; Cloete R; Fielding BC
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antivirals for Broader Coverage against Human Coronaviruses.
    Outteridge M; Nunn CM; Devine K; Patel B; McLean GR
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics.
    Chakraborty C; Sharma AR; Bhattacharya M; Saha RP; Ghosh S; Biswas S; Samanta S; Sharma G; Agoramoorthy G; Lee SS
    Infect Genet Evol; 2021 Apr; 89():104729. PubMed ID: 33497837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.
    Lau SKP; Lung DC; Wong EYM; Aw-Yong KL; Wong ACP; Luk HKH; Li KSM; Fung J; Chan TTY; Tang JYM; Zhu L; Yip CCY; Wong SCY; Lee RA; Tsang OTY; Yuen KY; Woo PCY
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.
    Zhao X; Sehgal M; Hou Z; Cheng J; Shu S; Wu S; Guo F; Le Marchand SJ; Lin H; Chang J; Guo JT
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment.
    Karaba AH; Johnston TS; Beck E; Laeyendecker O; Cox AL; Klein SL; Sullivan DJ;
    mBio; 2023 Feb; 14(1):e0328722. PubMed ID: 36625657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity.
    Guzmán-Martínez O; Guardado K; Varela-Cardoso M; Trujillo-Rivera A; Gómez-Ñañez I; Ortiz-León MC; Espinosa R; Ramos C; Pérez-Carreón JI; López-Guerrero DV; Sampieri CL; Alanís-García AB; Rojas-Durán F; Zenteno-Cuevas R; Gutiérrez M; Montero H
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.